Imara Inc IMRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
4.97UNCH (UNCH)
Volume
336
Close
4.97quote price arrow up+0.27 (+5.74%)
Volume
160,777
52 week range
0.97 - 5.26
Loading...
  • Open4.57
  • Day High5.14
  • Day Low4.57
  • Prev Close4.70
  • 52 Week High5.26
  • 52 Week High Date11/11/22
  • 52 Week Low0.97
  • 52 Week Low Date04/13/22

Key Stats

  • Market Cap130.648M
  • Shares Out26.29M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change21.52

KEY STATS

  • Open4.57
  • Day High5.14
  • Day Low4.57
  • Prev Close4.70
  • 52 Week High5.26
  • 52 Week High Date11/11/22
  • 52 Week Low0.97
  • 52 Week Low Date04/13/22
  • Market Cap130.648M
  • Shares Out26.29M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change21.52

RATIOS/PROFITABILITY

  • EPS (TTM)-1.71
  • P/E (TTM)-2.90
  • Fwd P/E (NTM)-25.36
  • EBITDA (TTM)-44.51M
  • ROE (TTM)-57.47%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Imara Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Imara, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687...
David Mott
Independent Chairman of the Board
Rahul Ballal Ph.D.
President, Chief Executive Officer, Director
Michael Gray
Chief Financial Officer, Chief Operating Officer
Address
1309 Beacon Street, Suite 300
Brookline, MA
02446
United States

Top Peers

SYMBOLLASTCHG%CHG
TIL
Instil Bio Inc
0.8902-0.0014-0.157%
BDTX
Black Diamond Therapeutics Inc
3.00+0.09+3.09%
ATOS
Atossa Therapeutics Inc
0.83UNCHUNCH
ELYM
Eliem Therapeutics Inc
3.37-0.15-4.26%
GRPH
Graphite Bio Inc
2.07-0.11-5.05%
EVLO
Evelo Biosciences Inc
0.9099+0.055+6.4335%